Pretreatment neutrophil‐lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor‐mutant non‐small cell lung cancer patients treated with tyrosine kinase inhibitors

BACKGROUND: The neutrophil‐lymphocyte ratio (NLR) is a marker of poor prognosis in lung cancer patients. However, previous data have been based on an heterogeneous population of lung cancer patients and various treatments. In this study, we evaluate the prognostic value of NLR in an homogeneous popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Sung Hoon, Beom, Seung‐Hoon, Ahn, Yong‐Oon, Keam, Bhumsuk, Kim, Tae Min, Lee, Se‐Hoon, Kim, Dong‐Wan, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773306/
https://www.ncbi.nlm.nih.gov/pubmed/27042217
http://dx.doi.org/10.1111/1759-7714.12304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773306/
https://www.ncbi.nlm.nih.gov/pubmed/27042217
http://dx.doi.org/10.1111/1759-7714.12304

Ejemplares similares